Crystallisation of polymorphs: Thermodynamic insight into the role of solvent

被引:152
作者
Threlfall, T [1 ]
机构
[1] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England
关键词
D O I
10.1021/op000058y
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
Dependent on the conditions, crystallisation of polymorphs from solvent may be under kinetic or thermodynamic control. In the latter case the nature of the solvent will be immaterial in respect of the polymorph produced. The conditions under which each of these factors may apply are analysed in detail. The transition point between two dimorphs may not present a sharp divide in which crystallisation above and below the transition temperature produces the high melting and the low melting polymorph, respectively. It is shown that even in those cases where the choice of solvent appears to be critical this may be a secondary effect related to the concentration attainable in that solvent at a certain temperature rather than a specific effect dependent on solvent-solute interaction, A corollary to these considerations is the necessity to determine solubility curves and metastable zone widths in order to be able to control polymorph crystallisation.
引用
收藏
页码:384 / 390
页数:7
相关论文
共 20 条
[1]   Sulfathiazole polymorphism studied by magic-angle spinning NMR [J].
Apperley, DC ;
Fletton, RA ;
Harris, RK ;
Lancaster, RW ;
Tavener, S ;
Threlfall, TL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1999, 88 (12) :1275-1280
[2]   Seeding the desired polymorph: Background, possibilities, limitations, and case studies [J].
Beckmann, W .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2000, 4 (05) :372-383
[3]  
Bernstein J, 1999, ANGEW CHEM INT EDIT, V38, P3440, DOI 10.1002/(SICI)1521-3773(19991203)38:23<3440::AID-ANIE3440>3.0.CO
[4]  
2-#
[5]   Crystal chemistry and solvent effects in polymorphic systems - Sulfathiazole [J].
Blagden, N ;
Davey, RJ ;
Lieberman, HF ;
Williams, L ;
Payne, R ;
Roberts, R ;
Rowe, R ;
Docherty, R .
JOURNAL OF THE CHEMICAL SOCIETY-FARADAY TRANSACTIONS, 1998, 94 (08) :1035-1044
[6]  
Burger A, 2000, J PHARM SCI-US, V89, P457, DOI 10.1002/(SICI)1520-6017(200004)89:4<457::AID-JPS3>3.0.CO
[7]  
2-G
[8]   PHARMACEUTICAL SOLIDS - A STRATEGIC APPROACH TO REGULATORY CONSIDERATIONS [J].
BYRN, S ;
PFEIFFER, R ;
GANEY, M ;
HOIBERG, C ;
POOCHIKIAN, G .
PHARMACEUTICAL RESEARCH, 1995, 12 (07) :945-954
[9]  
Cardew P., 1982, TAILORING CRYSTAL GR
[10]  
GAVEZOTTI CA, 1997, THEORETICAL ASPECTS, V2